Patents by Inventor Malgorzata E. Wilinska

Malgorzata E. Wilinska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11246986
    Abstract: A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: February 15, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka
  • Publication number: 20210361867
    Abstract: A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).
    Type: Application
    Filed: August 10, 2021
    Publication date: November 25, 2021
    Applicants: Abbott Diabetes Care Inc., Cambridge Enterprise Limited
    Inventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka
  • Publication number: 20190151540
    Abstract: A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).
    Type: Application
    Filed: January 18, 2019
    Publication date: May 23, 2019
    Applicants: Abbott Diabetes Care Inc., Cambridge Enterprise Limited
    Inventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka
  • Publication number: 20170135643
    Abstract: A system and method for reducing the number of hypoglycemic alarms presented to a user is presented. The system and methods include use of model based state estimation and variable-delayed threshold values to balance the risk of not presenting an alarm caused by an actual hypoglycemic state with the presentation of alarms caused by artifacts in the signals produced by a continuous glucose monitor.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 18, 2017
    Inventors: Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka, Malgorzata E. Wilinska, David Dunger
  • Publication number: 20170080152
    Abstract: A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).
    Type: Application
    Filed: June 27, 2016
    Publication date: March 23, 2017
    Inventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka
  • Patent number: 9402953
    Abstract: A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: August 2, 2016
    Assignees: ABBOTT DIABETES CARE INC., CAMBRIDGE ENTERPRISE LIMITED
    Inventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka
  • Publication number: 20140081236
    Abstract: A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).
    Type: Application
    Filed: November 18, 2013
    Publication date: March 20, 2014
    Applicants: ABBOTT DIABETES CARE INC., Cambridge Enterprise Limited, CAMBRIDGE UNIVERSITY LIMITED
    Inventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka
  • Patent number: 8585637
    Abstract: A closed-loop method for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: November 19, 2013
    Assignees: Abbott Diabetes Care Inc., Cambridge Enterprise Limited
    Inventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka
  • Publication number: 20120010600
    Abstract: A closed-loop method for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).
    Type: Application
    Filed: September 22, 2011
    Publication date: January 12, 2012
    Applicants: CAMBRIDGE ENTERPRISE LIMITED, ABBOTT DIABETES CARE INC.
    Inventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka
  • Patent number: 8062249
    Abstract: A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: November 22, 2011
    Assignees: Abbott Diabetes Care Inc., Cambridge Enterprise Limited
    Inventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka
  • Publication number: 20100280441
    Abstract: A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”).
    Type: Application
    Filed: March 31, 2010
    Publication date: November 4, 2010
    Applicants: ABBOTT DIABETES CARE INC., CAMBRIDGE ENTERPRISE LIMITED
    Inventors: Malgorzata E. Wilinska, Erwin S. Budiman, Gary A. Hayter, Marc B. Taub, Roman Hovorka